| pubmed-article:15284712 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15284712 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:15284712 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:15284712 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:15284712 | lifeskim:mentions | umls-concept:C1513884 | lld:lifeskim |
| pubmed-article:15284712 | lifeskim:mentions | umls-concept:C0593802 | lld:lifeskim |
| pubmed-article:15284712 | lifeskim:mentions | umls-concept:C0449438 | lld:lifeskim |
| pubmed-article:15284712 | lifeskim:mentions | umls-concept:C1273870 | lld:lifeskim |
| pubmed-article:15284712 | lifeskim:mentions | umls-concept:C0010341 | lld:lifeskim |
| pubmed-article:15284712 | lifeskim:mentions | umls-concept:C0521116 | lld:lifeskim |
| pubmed-article:15284712 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:15284712 | pubmed:dateCreated | 2004-7-30 | lld:pubmed |
| pubmed-article:15284712 | pubmed:abstractText | The third-generation aromatase inhibitors reduce circulating estrogen levels in postmenopausal women and are well tolerated orally for breast cancer. Their role in the management of advanced breast cancer has already been recognized. This article reviews the evidence for their role in the adjuvant treatment of early-stage disease. | lld:pubmed |
| pubmed-article:15284712 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15284712 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15284712 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15284712 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15284712 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15284712 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15284712 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15284712 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15284712 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15284712 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15284712 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15284712 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15284712 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15284712 | pubmed:issn | 1526-2359 | lld:pubmed |
| pubmed-article:15284712 | pubmed:author | pubmed-author:BaumMichaelM | lld:pubmed |
| pubmed-article:15284712 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:15284712 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:15284712 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15284712 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15284712 | pubmed:pagination | 217-21 | lld:pubmed |
| pubmed-article:15284712 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:15284712 | pubmed:meshHeading | pubmed-meshheading:15284712... | lld:pubmed |
| pubmed-article:15284712 | pubmed:meshHeading | pubmed-meshheading:15284712... | lld:pubmed |
| pubmed-article:15284712 | pubmed:meshHeading | pubmed-meshheading:15284712... | lld:pubmed |
| pubmed-article:15284712 | pubmed:meshHeading | pubmed-meshheading:15284712... | lld:pubmed |
| pubmed-article:15284712 | pubmed:meshHeading | pubmed-meshheading:15284712... | lld:pubmed |
| pubmed-article:15284712 | pubmed:meshHeading | pubmed-meshheading:15284712... | lld:pubmed |
| pubmed-article:15284712 | pubmed:meshHeading | pubmed-meshheading:15284712... | lld:pubmed |
| pubmed-article:15284712 | pubmed:meshHeading | pubmed-meshheading:15284712... | lld:pubmed |
| pubmed-article:15284712 | pubmed:meshHeading | pubmed-meshheading:15284712... | lld:pubmed |
| pubmed-article:15284712 | pubmed:meshHeading | pubmed-meshheading:15284712... | lld:pubmed |
| pubmed-article:15284712 | pubmed:meshHeading | pubmed-meshheading:15284712... | lld:pubmed |
| pubmed-article:15284712 | pubmed:meshHeading | pubmed-meshheading:15284712... | lld:pubmed |
| pubmed-article:15284712 | pubmed:meshHeading | pubmed-meshheading:15284712... | lld:pubmed |
| pubmed-article:15284712 | pubmed:meshHeading | pubmed-meshheading:15284712... | lld:pubmed |
| pubmed-article:15284712 | pubmed:meshHeading | pubmed-meshheading:15284712... | lld:pubmed |
| pubmed-article:15284712 | pubmed:meshHeading | pubmed-meshheading:15284712... | lld:pubmed |
| pubmed-article:15284712 | pubmed:meshHeading | pubmed-meshheading:15284712... | lld:pubmed |
| pubmed-article:15284712 | pubmed:meshHeading | pubmed-meshheading:15284712... | lld:pubmed |
| pubmed-article:15284712 | pubmed:meshHeading | pubmed-meshheading:15284712... | lld:pubmed |
| pubmed-article:15284712 | pubmed:articleTitle | Current status of aromatase inhibitors in the management of breast cancer and critique of the NCIC MA-17 trial. | lld:pubmed |
| pubmed-article:15284712 | pubmed:affiliation | University College London, The Portland Hospital, London, UK. michael@mbaum.freeserve.co.uk | lld:pubmed |
| pubmed-article:15284712 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15284712 | pubmed:publicationType | Review | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15284712 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15284712 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15284712 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15284712 | lld:pubmed |
